Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

FC-1271a

Known as: FC-1271 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Objective: To review the pharmacology, efficacy, and safety of ospemifene in the management of dyspareunia. Data Sources… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2004
2004
Tamoxifen has been used for the treatment of breast cancer since the 1970s, but is considered a carcinogen because it has been… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
OBJECTIVE Selective estrogen receptor modulators (SERMs) are drugs that exhibit both estrogen agonistic and antagonistic effects… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Ospemifene (FC-1271a) is a novel selective estrogen receptor modulator under development for osteoporosis prevention. In the… Expand
Is this relevant?
2000
2000
AbstractPurpose: New selective estrogen-receptor modulators for the treatment and prevention of osteoporosis, cardiovascular… Expand
Is this relevant?
1999
1999
A highly sensitive and precise high-performance liquid chromatography (HPLC) assay was developed and validated for the… Expand
Is this relevant?